Institute of Neuroradiology, Faculty of Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Fetscherstraße 74, 01307, Dresden, Germany.
Dresden Neurovascular Center, University Hospital Carl Gustav Carus, Dresden, Germany.
Clin Neuroradiol. 2024 Mar;34(1):125-133. doi: 10.1007/s00062-023-01342-7. Epub 2023 Sep 4.
The benefit of endovascular treatment (EVT) in patients with acute symptomatic isolated occlusion of the internal carotid artery (ICA) without involvement of the middle and anterior cerebral arteries is unclear. We aimed to compare clinical and safety outcomes of best medical treatment (BMT) versus EVT + BMT in patients with stroke due to isolated ICA occlusion.
We conducted a retrospective multicenter study involving patients with isolated ICA occlusion between January 2016 and December 2020. We stratified patients by BMT versus EVT and matched the groups using propensity score matching (PSM). We assessed the effect of treatment strategy on favorable outcome (modified Rankin scale ≤ 2) 90 days after treatment and compared reduction in NIHSS score at discharge, rates of symptomatic intracranial hemorrhage (sICH) and 3‑month mortality.
In total, we included 149 patients with isolated ICA occlusion. To address imbalances, we matched 45 patients from each group using PSM. The rate of favorable outcomes at 90 days was 56% for EVT and 38% for BMT (odds ratio, OR 1.89, 95% confidence interval, CI 0.84-4.24; p = 0.12). Patients treated with EVT showed a median reduction in NIHSS score at discharge of 6 points compared to 1 point for BMT patients (p = 0.02). Rates of symptomatic intracranial hemorrhage (7% vs. 4%; p = 0.66) and 3‑month mortality (11% vs. 13%; p = 0.74) did not differ between treatment groups. Periprocedural complications of EVT with early neurological deterioration occurred in 7% of cases.
Although the benefit on functional outcome did not reach statistical significance, the results for NIHSS score improvement, and safety support the use of EVT in patients with stroke due to isolated ICA occlusion.
急性症状性颈内动脉(ICA)孤立性闭塞而不累及大脑中动脉和前动脉的患者,血管内治疗(EVT)的获益尚不清楚。我们旨在比较单纯 ICA 闭塞引起的卒中患者最佳药物治疗(BMT)与 EVT+BMT 的临床和安全性结局。
我们进行了一项回顾性多中心研究,纳入了 2016 年 1 月至 2020 年 12 月期间 ICA 孤立性闭塞的患者。我们根据 BMT 与 EVT 对患者进行分层,并使用倾向评分匹配(PSM)对两组进行匹配。我们评估了治疗策略对治疗后 90 天时良好结局(改良 Rankin 量表≤2)的影响,并比较了出院时 NIHSS 评分的降低、症状性颅内出血(sICH)发生率和 3 个月死亡率。
共纳入 149 例 ICA 孤立性闭塞患者。为了消除不平衡,我们使用 PSM 对每组匹配了 45 例患者。EVT 组 90 天的良好结局率为 56%,BMT 组为 38%(优势比,OR 1.89,95%置信区间,CI 0.84-4.24;p=0.12)。与 BMT 患者相比,EVT 治疗患者出院时 NIHSS 评分中位数降低 6 分(p=0.02)。症状性颅内出血(7%比 4%;p=0.66)和 3 个月死亡率(11%比 13%;p=0.74)在两组之间无差异。EVT 的围手术期并发症伴早期神经功能恶化的发生率为 7%。
尽管功能结局的获益未达到统计学意义,但 NIHSS 评分改善和安全性方面的结果支持对单纯 ICA 闭塞引起的卒中患者使用 EVT。